dostarlimab
gsk
['rectal', 'dostarlimab']
simultaneous presentation at #asco22 and publication in the nejm. dostarlimab achieves 100 percent clinical response on mmr defecienr stage ii and iii rectal cancer!!!! pt avoided chemotherapy , radiation therapy and surgery! 
A dedicated conference for oncology held under the theme "Access. Educate. Collaborate"